Adaptation and constraint at Toll-like receptors in primates.
Frequent positive selection is a hallmark of genes involved in the adaptive immune system of vertebrates, but the incidence of positive selection for genes underlying innate immunity in vertebrates has not been well studied. The toll-like receptors (TLRs) of the innate immune system represent the first line of defense against pathogens. TLRs lie directly at the host-environment interface, and they target microbial molecules. Because of this, they might be subject to frequent positive selection due to coevolutionary dynamics with their microbial counterparts. However, they also recognize conserved molecular motifs, and this might constrain their evolution. Here, we investigate the evolution of the ten human TLRs in the framework of these competing ideas. We studied rates of protein evolution among primate species and we analyzed patterns of polymorphism in humans and chimpanzees. This provides a window into TLR evolution at both long and short timescales. We found a clear signature of positive selection in the rates of substitution across primates in most TLRs. Some of the implicated sites fall in structurally important protein domains, involve radical amino acid changes, or overlap with polymorphisms with known clinical associations in humans. However, within species, patterns of nucleotide variation were generally compatible with purifying selection, and these patterns differed between humans and chimpanzees and between viral and nonviral TLRs. Thus, adaptive evolution at TLRs does not appear to reflect a constant turnover of alleles and instead might be more episodic in nature. This pattern is consistent with more ephemeral pathogen-host associations rather than with long-term coevolution.
Wlasiuk
Gabriela
G
Department of Ecology and Evolutionary Biology, University of Arizona, AZ, USA. wlasiuk@email.arizona.edu
Nachman
Michael W
MW
D000818:Animals; D019143:Evolution, Molecular; D006801:Humans; D011323:Primates / Q000235:genetics*; D051193:Toll-Like Receptors / Q000145:classification / Q000235:genetics*
D051193:Toll-Like Receptors
Nature. 2008 Dec 4;456(7222):658-62
18820679
Int J Cancer. 2008 Dec 1;123(11):2644-50
18752252
Biochem J. 2009 Apr 28;420(1):1-16
19382893
Genes Immun. 2008 Sep;9(6):483-92
18528403
PLoS Genet. 2009 Jul;5(7):e1000562
19609346
Bioinformatics. 2003 Nov 22;19(17):2325-7
14630667
Genetics. 2002 May;161(1):269-74
12019240
Genetics. 1989 Nov;123(3):585-95
2513255
Bioinformatics. 2005 May 15;21(10):2531-3
15713735
Immunity. 2005 Aug;23(2):165-75
16111635
Theor Popul Biol. 1975 Apr;7(2):256-76
1145509
Genetics. 2001 Aug;158(4):1657-64
11514453
Proc Natl Acad Sci U S A. 1979 Oct;76(10):5269-73
291943
J Immunol. 2007 May 15;178(10):6387-94
17475868
Genetics. 1998 Mar;148(3):929-36
9539414
PLoS Biol. 2004 Oct;2(10):e286
15361935
Cell. 2007 Sep 21;130(6):1071-82
17889651
Hum Mol Genet. 2001 Mar 15;10(6):591-7
11230178
Nature. 1991 Jun 20;351(6328):652-4
1904993
Mol Biol Evol. 2009 Apr;26(4):937-49
19179655
Nature. 2008 Feb 21;451(7181):994-7
18288194
Bioinformatics. 2009 Jun 1;25(11):1451-2
19346325
Nat Genet. 2007 Dec;39(12):1461-8
17987029
Mol Biol Evol. 2008 Feb;25(2):383-92
18056076
Genetics. 2000 Jul;155(3):1405-13
10880498
Nature. 2007 Mar 29;446(7135):507-12
17392779
Mol Biol Evol. 2005 Dec;22(12):2375-85
16107593
J Immunol. 2008 Jul 15;181(2):1315-22
18606686
J Exp Med. 2003 Nov 17;198(10):1563-72
14623910
Nature. 2009 Apr 30;458(7242):1191-5
19252480
Cell Microbiol. 2007 Aug;9(8):1891-901
17521328
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2832-7
15689398
Mol Biol Evol. 2007 Aug;24(8):1586-91
17483113
Mol Biol Evol. 2005 May;22(5):1208-22
15703242
Genetics. 1973 Sep;75(1):199-212
4762875
PLoS Biol. 2006 Mar;4(3):e72
16494531
Science. 2007 Apr 13;316(5822):222-34
17431167
Nature. 2009 Jan 22;457(7228):485-9
19043403
Genetics. 1987 May;116(1):153-9
3110004
J Infect Dis. 2009 Jun 15;199(12):1816-9
19456232
Immunogenetics. 2008 Dec;60(12):727-35
18810425
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9577-82
15976025
Mol Biol Evol. 2005 Apr;22(4):1107-18
15689528
Mol Biol Evol. 1996 Jul;13(6):735-48
8754210
Nat Immunol. 2004 Feb;5(2):190-8
14716310
Mol Biol Evol. 1998 May;15(5):568-73
9580986
Annu Rev Genomics Hum Genet. 2006;7:61-80
16824020
Genetics. 2000 May;155(1):431-49
10790415
J Allergy Clin Immunol. 2004 Sep;114(3):561-7
15356557
Cell. 2006 Feb 24;124(4):783-801
16497588
Am J Respir Crit Care Med. 2004 Sep 15;170(6):594-600
15201134
Comput Appl Biosci. 1997 Oct;13(5):555-6
9367129
Curr Biol. 2006 Jun 6;16(11):1133-8
16753568
Nature. 2007 Jun 7;447(7145):661-78
17554300
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15754-7
14660790
J Immunol. 2007 Jun 15;178(12):7520-4
17548585
PLoS Biol. 2004 Sep;2(9):E275
15269786
J Immunol. 2002 Jul 1;169(1):10-4
12077222
J Allergy Clin Immunol. 2008 Jul;122(1):86-92, 92.e1-8
18547625
Nat Rev Immunol. 2004 Jul;4(7):499-511
15229469
Science. 2008 Apr 18;320(5874):379-81
18420935
Nat Genet. 2000 Jun;25(2):187-91
10835634
Genetics. 2003 Aug;164(4):1511-8
12930756
N Engl J Med. 2002 Jul 18;347(3):185-92
12124407
Protein Sci. 2009 Aug;18(8):1684-91
19521997
Eur J Immunol. 2007 Aug;37(8):2280-9
17595679
PLoS One. 2007 Dec 19;2(12):e1318
18091991
Genetics. 2004 Mar;166(3):1375-83
15082556
Lancet Infect Dis. 2005 Mar;5(3):156-64
15766650
Infect Immun. 2000 Nov;68(11):6398-401
11035751
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7073-8
19359493
Immunol Rev. 2007 Dec;220:251-69
17979852
Nat Genet. 2007 Jul;39(7):857-64
17554260
Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
9396791
Genetics. 2007 Dec;177(4):2195-207
18073427
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10593-7
16027372
Mol Biol Evol. 2005 Feb;22(2):297-307
15483319
Genetics. 1993 Mar;133(3):693-709
8454210
BMC Genomics. 2007 May 21;8:124
17517123
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):862-6
16702361